drugset / Trial / NCT00710697

Cardiac Safety Assessment Study of Picoplatin in Solid Tumors

NCT00710697

Phase 1 Unknown 40 enrolled Poniard Pharmaceuticals
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate what effects, if any, picoplatin has on the heart rhythm.

Timeline

Start
2008-06
Primary completion
2009-03
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Picoplatin Small molecule 150 mg/m2 Intravenous

Indications